Brief: InspireMD Reports Publication of 12-Month Results of CGuard EPS SIBERIA Trial
03/11/2021 22:05
Nov 3 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD ANNOUNCES PUBLICATION OF 12-MONTH RESULTS OF
CGUARD™
EPS SIBERIA TRIAL IN JOURNALS OF THE AMERICAN COLLEGE OF
CARDIOLOGY: CARDIOVASCULAR INTERVENTIONS
Source text for Eikon: ID:nGNX88b4R9
Further company coverage: NSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InspireMD
See all newsInspireMD Inc reports results for the quarter ended June 30 - Earnings Summary
InspireMD Q2 revenue beats estimates on international demand
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Q1 revenue jumps 122%, beats estimates on product demand